Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)-Reference-Cited by-同舟云学术

Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)

Published:2023-05 Issue:5 Volume:29 Page:651.e1-651.e8
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Wingen-Heimann Sebastian M.,Davies Kerrie,Viprey Virginie F.,Davis Georgina,Wilcox Mark H.,Vehreschild Maria J.G.T.,Lurienne Lise,Bandinelli Pierre-Alain,Cornely Oliver A.,Vilken Tuba,Hopff Sina M.,Vehreschild Jörg Janne,Academic Partners ,Bonten Marc,Davies Kerrie A.,Wilcox Mark H.,Kuijper Ed,Rupnik Maja,Wingen-Heimann Sebastian,Tacconelli Evelina,Vilken Tuba,Petrosillo Nicola,EFPIA Partners ,Pfizer Ltd ,GlaxoSmithKline ,bioMérieux ,Pasteur Sanofi,Da Volterra ,The Management Board of COMBACTE-CDI ,Cleuziat Philippe,Webber Chris

Funder

Innovative Medicines Initiative

Horizon 2020

European Federation of Pharmaceutical Industries and Associations

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference39 articles.

1. Clostridium difficile--more difficult than ever;Kelly;N Engl J Med,2008

2. Clostridium difficile infection in Europe: a hospital-based survey;Bauer;Lancet,2011

3. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates;Barbut;Clin Microbiol Infect,2007